El desarrollo ha sido calificado como “droga mágica”: ¿lo es? A quiénes está destinado este nuevo tratamiento que además mejora la salud cardiovascular ...
Uno de los mitos que circula en el ámbito de la ciberseguridad es que las pequeñas y medianas empresas (también llamadas pymes) no son atractivas para el cibercrimen ya que son “demasiado pequeñas”, ...
Sure, Eli Lilly’s Tirzepatide-based drugs have caught up significantly to Novo Nordisk’s semaglutide-based ones. As a result, ...
Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, as the obesity ...
Discover how potential U.S. price cuts on obesity drugs could impact LLY and NVO revenues, stock sentiment, and valuation ...
Novo Nordisk is drawing divided views from Wall Street analysts. Some may be disappointed by the loss of market share to Eli Lilly. Three events could turn sentiment positive in the coming months. The ...
Novo Nordisk is drawing divided views from Wall Street analysts. Some may be disappointed by the loss of market share to Eli Lilly. Three events could turn sentiment positive in the coming months. 10 ...
Carolina Wealth Advisors, LLC added 102,629 shares of Novo Nordisk A/S, an estimated $6.01 million trade based on the average price for Q3 2025. The trade represented 2.6% of reportable AUM for the ...
“[T]he Third Circuit found that CMS’ treatment of six [Novo Nordisk] products as a single drug was ultimately precluded by the IRA’s bar against judicial review.” Yesterday, the U.S. Court of Appeals ...
CHICAGO (Reuters) -A federal appeals court on Monday rejected Novo Nordisk's challenge to the U.S. government’s program that gives its Medicare health insurance plan the power to negotiate lower drug ...